NCT05228002 - sFlt-1/PlGF Ratio: Impact on the Management of Patients With Suspected Pre-eclampsia | Biotech Hunter

Enrollment

43

Participants

Timeline

Start Date

May 23, 2023

Primary Completion Date

March 3, 2025

Study Completion Date

March 3, 2025

Conditions

Pre-Eclampsia

Interventions

OTHER

sFlt-1/PlGF ratio - Active Comparator: Standard

"Blood test for biomarkers (sFlt-1/PlGF ratio) For patients in the standard group, the biomarker results will be masked and then revealed afterwards for statistical analysis.~For the biomarkers group, the monitoring decision will be made based on the ratio calculation"

OTHER

sFlt-1/PlGF ratio - Experimental: Biomarkers

"Blood test for biomarkers (sFlt-1/PlGF ratio) For patients in the standard group, the biomarker results will be masked and then revealed afterwards for statistical analysis.~For the biomarkers group, the monitoring decision will be made based on the ratio calculation."

Trial Locations (1)

Unknown

Nice University Hospital, Nice